|
TMEM161B expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62447832963153E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.66133814775094E-16 |
| Normal-vs-Stage2 |
3.31190000002479E-06 |
| Normal-vs-Stage3 |
1.52766688188422E-13 |
| Normal-vs-Stage4 |
1.52679979770198E-10 |
| Stage1-vs-Stage2 |
3.314600E-01 |
| Stage1-vs-Stage3 |
2.165800E-01 |
| Stage1-vs-Stage4 |
3.822600E-01 |
| Stage2-vs-Stage3 |
9.254400E-02 |
| Stage2-vs-Stage4 |
1.627430E-01 |
| Stage3-vs-Stage4 |
9.468000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.11022302462516E-16 |
| Normal-vs-AfricanAmerican |
5.87559999999376E-05 |
| Normal-vs-Asian |
1.00190000740241E-09 |
| Caucasian-vs-AfricanAmerican |
1.985050E-01 |
| Caucasian-vs-Asian |
7.943800E-01 |
| AfricanAmerican-vs-Asian |
3.346800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.50990331349021E-14 |
| Normal-vs-Female |
1.62847513252018E-12 |
| Male-vs-Female |
3.779400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.72795111552659E-12 |
| Normal-vs-Age(41-60Yrs) |
1.45439216225896E-14 |
| Normal-vs-Age(61-80Yrs) |
6.3381000448004E-10 |
| Normal-vs-Age(81-100Yrs) |
3.591100E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.667600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.683600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.043800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.438780E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.995200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.746600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.829380E-01 |
| Classical-VS-Follicular |
8.145800E-02 |
| Classical-VS-Other |
4.188600E-01 |
| Classical-VS-Normal |
1.62503344114384E-12 |
| Tall-VS-Follicular |
1.097660E-02 |
| Tall-VS-Other |
8.820000E-01 |
| Tall-VS-Normal |
5.00629537825148E-11 |
| Follicular-VS-Other |
2.348400E-01 |
| Follicular-VS-Normal |
1.29289999994953E-06 |
| Other-VS-Normal |
3.031900E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.54161144855425E-14 |
| Normal-vs-N1 |
5.07270003780036E-10 |
| N0-vs-N1 |
6.095800E-01 |
|
|
